Clinical observation on proteinuria treatment in hypertension and type 2 diabetes with enalaprilat joint losartan
10.3760/cma.j.issn.1008-6706.2011.16.022
- VernacularTitle:依那普利联合氯沙坦在高血压并发2型糖尿病患者蛋白尿治疗中的应用
- Author:
Guoqing LV
;
Guiping GAO
- Publication Type:Journal Article
- Keywords:
Enalaprilat;
Losartan;
Hpertension;
Type 2 diabetes
- From:
Chinese Journal of Primary Medicine and Pharmacy
2011;18(16):2205-2206
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo observe clinical effect of proteinuria treatment in hypertension and type 2 diabetes with enalaprilat joint losartan. Methods72 cases of hypertension and type 2 diabetes with proteinuria patients were divided into two groups randomiy,losartan and enalaprilat combination for the treatment group( n =36) ,losartan alone for the observation group( n =36) ,treatment 14 weeks. Observed two groups of blood pressure and 24h after treatment urinary albumin excretion rate. ResultsTwo groups of blood pressure than before treatment were reduced significantly(P ＜ 0.05), but after treatment between the two groups, the difference was not statistically significant (P ＞ 0.05 ).Two groups of patients after 14 weeks treatment, average 24h urine albumin excretion rate form( 105.2 ± 27.3 ) μg/min, ( 110. 3 ± 28.0) μg/min fell to(72.6 ± 26.5 ) μg/min, ( 87.5 ± 24.9 ) μg/min ( P ＜ 0. 01 ), the treatment group reduced more significant(P ＜0.05). ConclusionEnalaprilat joint losartan treatment at the same time,the effective step-down pressure, could improve the type 2 diabetes patients with early renal damage, and it suggested the early renal damage patients should be combined antihypertensive therapy as soon as possible.
